Boundless Bio, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Burow Kristina | — | Purchase | 133,333 | $16.00 | $2,133,328 | 1,181,766 | Apr 2, 2024 |
| Lim Jonathan E | — | C | 525,274 | — | — | 550,915 | Apr 2, 2024 |
| GILLIS STEVEN | — | Purchase | 66,667 | $16.00 | $1,066,672 | 683,759 | Apr 2, 2024 |
| ARCH Venture Partners IX, LLC | — | C | 589,743 | — | — | 617,092 | Apr 2, 2024 |
| Kolchinsky Peter | — | Purchase | 296,875 | $16.00 | $4,750,000 | 1,884,787 | Apr 2, 2024 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | — | C | 189,933 | — | — | 189,933 | Apr 2, 2024 |